Sunshine Biopharma, Inc.
Sunshine Biopharma, Inc. (SBFM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SBFM · as of Jun 9, 2026
Key Statistics
Explore Sunshine Biopharma, Inc. Data
sbfm stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
sbfm competitorsSBFM
ACXP
BFRI
CHEK
EVOK
HCWBStock Performance
Full HistoryAbout Sunshine Biopharma, Inc.
Sunshine Biopharma, Inc. operates as a pharmaceutical entity and a provider of nutritional supplements, primarily dedicating its efforts to the research and development of novel anticancer therapies. …
what is sunshine biopharma, inc. · sbfm stock overview · sunshine biopharma, inc. company profile · who is sunshine biopharma, inc. ceo · sbfm NASDAQ · sunshine biopharma, inc. headquarters · sunshine biopharma, inc. business segments
About Stock Overview & Key Data
Sunshine Biopharma, Inc. (SBFM) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Feb 15, 2022. As of the latest trading session, SBFM stock price is $2.43, with a market capitalization of $1.2M. The stock has returned -84.52% over the past 12 months and -80.24% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Sunshine Biopharma, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Sunshine Biopharma, Inc. reported revenue of $36.3M and net income of -$6.0M. For detailed data — including Sunshine Biopharma, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Sunshine Biopharma, Inc. (SBFM) stock price is $2.43. The stock is traded on NASDAQ under the ticker symbol SBFM. The 52-week range is $2.11 – $24.30.